NCT01984268View on ClinicalTrials.gov

ACTHAR for Acute Treatment of Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate

PHASE2TerminatedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

June 23, 2014

Primary Completion Date

September 1, 2016

Study Completion Date

September 1, 2016

Conditions

Rheumatoid Arthritis

Interventions

DRUG

ACTHAR

Trial Locations (1)

03756

Dartmouth-Hitchcock Medical Center, Lebanon

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Mallinckrodt

INDUSTRY

lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT01984268 - ACTHAR for Acute Treatment of Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate | Biotech Hunter | Biotech Hunter